CMS Proposes Revisions to Medicare Payment Policies by 2027
CMS proposes crucial updates to Medicare payment policies for hospitals and home health agencies, ensuring compliance and enhancing service access.
Massive Medicare Fraud Scheme Uncovered: $1 Billion in Claims
A federal indictment unveils a Medicare fraud scheme exceeding $1 billion in claims, emphasizing the urgent need for enhanced detection and regulatory measures.
Impact of Medicare Moratorium on Solace Hospice of Southwest Virginia Operations
Discover how the Medicare moratorium impacts Solace Hospice's operations and the future of hospice care in Southwest Virginia amid healthcare regulations.
Medicare Fraud Investigation and Arrest in Connecticut
A Middletown business owner pleads guilty to nearly $2 million in Medicare fraud, involving falsified claims impacting beneficiaries across multiple states.
Challenges and Innovations in Prior Authorization in Insurance
Explore how prior authorization impacts patient care in insurance, and learn about innovations like electronic submissions for better healthcare outcomes.
Essential OIG Guidelines for Medicare Advantage Compliance Framework
Discover OIG's essential guidelines for Medicare Advantage compliance, highlighting fraud prevention and AI tools for effective healthcare practices.
Enhancing Compliance and Efficiency with AI in Healthcare Billing
Explore AI-assisted billing tools in healthcare, their compliance risks, and how to enhance efficiency while adhering to the False Claims Act.
CMS Implements Moratorium on Hospice and Home Care Provider Enrollment
CMS pauses enrollment of new hospice and home care providers to combat Medicare fraud. This regulatory measure is essential for protecting vulnerable populations.
High Denial Rates of Medicare Advantage Organizations Under Scrutiny
Explore concerns over high denial rates by Medicare Advantage organizations for vital services, addressing critical implications for patient care and access.
Medicare Drug Price Negotiation: Proposed Rules and Industry Implications
Learn about the proposed Medicare drug price negotiation rule and its implications on the pharmaceutical industry and state regulations.